NICE guidance on everolimus in combination with exemestane for treatment of advanced HER2-negative, hormone-receptor-positive breast cancer after endocrine therapy.
作者信息
Burke Martyn J, Garrett Zoe, George Elisabeth, Adler Amanda I
机构信息
National Institute for Health and Care Excellence, Piccadilly Plaza, Manchester M1 4BT, UK.
National Institute for Health and Care Excellence, Piccadilly Plaza, Manchester M1 4BT, UK.
出版信息
Lancet Oncol. 2013 Oct;14(11):1049-1050. doi: 10.1016/S1470-2045(13)70406-6. Epub 2013 Aug 28.
Abstract
摘要
Zotero 插件